ArticleMicrobial cell factories2008
Yeast cell factories for fine chemical and API production.
Article in Microbial cell factories, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Efficient Production of 4'-Hydroxydihydrochalcones Using Non-Conventional Yeast Strains.International journal of molecular sciences · 2024Article
- Genome sequence of the potential probiotic eukaryote3 Biotech · 2020Article
- Elevated temperatures do not trigger a conserved metabolic network response among thermotolerant yeasts.BMC microbiology · 2019Article
- Development of a promising microbial platform for the production of dicarboxylic acids from biorenewable resources.Biotechnology for biofuels · 2018Article
- Article
- Fine-tuning the P. pastoris iMT1026 genome-scale metabolic model for improved prediction of growth on methanol or glycerol as sole carbon sources.Microbial biotechnology · 2018Article
- Cellular factories for coenzyme QMicrobial cell factories · 2017Review
- Whole cell biocatalysts: essential workers from Nature to the industry.Microbial biotechnology · 2017Review
- Exploiting Self-organization in Bioengineered Systems: A Computational Approach.Frontiers in bioengineering and biotechnology · 2017Article
- Rapid enzyme regeneration results in the striking catalytic longevity of an engineered, single species, biocatalytic biofilm.Microbial cell factories · 2016Article
- Versatile biocatalysis of fungal cytochrome P450 monooxygenases.Microbial cell factories · 2016Review
- Fungal cytochrome P450 monooxygenases of Fusarium oxysporum for the synthesis of ω-hydroxy fatty acids in engineered Saccharomyces cerevisiae.Microbial cell factories · 2015Article
- Influence of operational parameters on the fluid-side mass transfer resistance observed in a packed bed bioreactor.AMB Express · 2015Article
- Coordinated induction of multi-gene pathways in Saccharomyces cerevisiae.Nucleic acids research · 2013Article
- Development of quantitative metabolomics for Pichia pastoris.Metabolomics : Official journal of the Metabolomic Society · 2012Article
- A novel method to prepare L-arabinose from xylose mother liquor by yeast-mediated biopurification.Microbial cell factories · 2011Article
- Xylitol production from xylose mother liquor: a novel strategy that combines the use of recombinant Bacillus subtilis and Candida maltosa.Microbial cell factories · 2011Article
- Genome-scale metabolic reconstruction and in silico analysis of methylotrophic yeast Pichia pastoris for strain improvement.Microbial cell factories · 2010Article
- Stepwise engineering of a Pichia pastoris D-amino acid oxidase whole cell catalyst.Microbial cell factories · 2010Article
- Effect of HXT1 and HXT7 hexose transporter overexpression on wild-type and lactic acid producing Saccharomyces cerevisiae cells.Microbial cell factories · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review gives an overview of different yeast strains and enzyme classes involved in yeast whole-cell biotransformations. A focus was put on the synthesis of compounds for fine chemical and API (= active pharmaceutical ingredient) production employing single or only few-step enzymatic reactions. Accounting for recent success stories in metabolic engineering, the construction and use of synthetic pathways was also highlighted. Examples from academia and industry and advances in the field of designed yeast strain construction demonstrate the broad significance of yeast whole-cell applications. In addition to Saccharomyces cerevisiae, alternative yeast whole-cell biocatalysts are discussed such as Candida sp., Cryptococcus sp., Geotrichum sp., Issatchenkia sp., Kloeckera sp., Kluyveromyces sp., Pichia sp. (including Hansenula polymorpha = P. angusta), Rhodotorula sp., Rhodosporidium sp., alternative Saccharomyces sp., Schizosaccharomyces pombe, Torulopsis sp., Trichosporon sp., Trigonopsis variabilis, Yarrowia lipolytica and Zygosaccharomyces rouxii.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.